CN
Think beyond. Innovate beyond !

Focus on providing precise, intelligent,and minimally invasive surgical solutions for ophthalmology.

Established in July 2022, Sierra Medical is an innovative medical device enterprise that integrates R&D, manufacturing, and sales, with a focus on providing precise, intelligent, and minimally invasive surgical solutions for ophthalmology.

The company specializes in the R&D of high-end ophthalmic surgical equipment and consumables, with a broad product portfolio covering major ophthalmic surgical fields including cataract and vitreoretinal diseases, providing comprehensive surgical solutions for clinical use.

Sierra Medical is committed to delivering innovative, high-quality products and services to ophthalmologists and patients, and to advancing the development of ophthalmic medical technologies.

未标题-4.png

Major Events
SINCE 2022
2026
June
RCT results of Sierra Medical‘s SIERRA VISION SYSTEM® were unveiled, demonstrating performance aligned with international benchmarks with solid clinical data.
April
SIERRA VISION SYSTEM® obtained the NMPA Medical Device Registration Certificate, representing a milestone breakthrough.
2025
December
Single-center clinical trial for NEXVIT® Single-Use Dual Blade Vitrectomy Probe kicked off, accelerating the product launch timeline.
December
GALUXY® Single-Use Laser Probe was approved for launch, enriching the company’s energy-based product pipeline.
November
Multi-center clinical trial for SIERRA VISION SYSTEM® was officially initiated.
September
Completed financing of over RMB 100 million, receiving strong recognition from the capital market.
August
Multi-center clinical trial for NEXVIT® Single-Use Dual Blade Vitrectomy Probe was successfully concluded, verifying the product’s safety and efficacy
June
National Congress on Ocular Trauma – SIERRA VISION SYSTEM® made its first public appearance, showcasing its innovative technological strengths.
April
Single-Use Ophthalmic Entry System approved, completing the company‘s surgical instrument product portfolio.
February
NEXVIT® Single-Use Dual Blade Vitrectomy Probe obtained the Medical Device Registration Certificate from the National Medical Products Administration (NMPA), marking a key breakthrough in core consumables.